On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
The current epidemic of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) calls for the development of inhibitors of viral replication. Here, we performed a bioinformatic analysis of published and purported SARS-CoV-2 antivirals including imatin...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13457
- Acceso en línea:
- https://www.nature.com/articles/s41419-020-02842-x
http://hdl.handle.net/20.500.12010/13457
https://doi.org/10.1038/s41419-020-02842-x
- Palabra clave:
- medicamentos que inhiben la replicación del SARS-CoV-2
epidemic of coronavirus disease
inhibitors of viral
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido